Phibro Animal Health | PAHC - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Align Technology USD 2M 660K 2023-03
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Assertio Holdings USD 758K 1000 2024-06
Aurora Cannabis CAD 2.11M 116K 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Canopy Growth CAD 7.34M 1.46M 2025-12
Corcept Therapeutics USD 823.61M 21.88M 2025-09
Eli Lilly USD 114.7M 134.3M 2025-09
Henry Schein USD 39M 1000K 2025-12
Idexx Laboratories USD 10.08M 1.24M 2025-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Merck USD 412M 85M 2025-12
Nektar Therapeutics USD 6.02M 420K 2024-09
Pacira USD 3.89M 387K 2025-12
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Supernus Pharmaceuticals USD 910K 278K 2023-06
Zoetis USD 57M 1000K 2025-12